Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis

Table 1 Demographic characteristics

	Group I( n = 34)	Group II( n = 60)	P value
Age (yr)	40.8 ± 6.8	42.3 ± 8.9	0.394
Initial TG	1 922 ± 1 287	1 913 ± 612	0.966
DM (%)	38(13/34)	55(33/60)	0.118
Alcohol (%)	44(15/34)	28.3 (17/60)	0.121
Ranson > 3(%)	20.6( 7/34)	36.7(22/60)	0.105
Balthazar D, E (%)	54.2(13/24)	41.3(19/46)	0.305

Table 2 Comparison of mortality and morbidity between patients before and after availability of plasma exchange

	Group I (%, n = 34)	Group II (%, n = 60)	P value
Mortality (%)	5.9(2/34)	6.7(4/60)	0.881
Systemic complications (%)	17.6(6/34)	18.3(11/60)	0.934
Local complications (%)	11.8(4/34)	6.7(4/60)	0.395

Table 3 Comparison of systemic complications between pa-tients before and after the availability of plasma exchange

	Group I (%, n = 34)	Group II (%, n = 60)	P value
ARF	17.6(6/34)	10(6/60)	0.286
UGI bleeding	0(0/34)	8.3(5/60)	0.084
Shock	8.8(3/34)	10(6/60)	0.852
ARDS	11.8(4/34)	10(6/60)	0.790

ARF: Acute renal failure; ARDS: Acute respiratory distress syndrome.

Table 4 Comparison of local complications between patients before and after availability of plasma exchange

	Group I (%, n = 34)	Group II (%, n = 60)	P value
Abscess	17.6(6/34)	10(6/60)	0.286
Pseudocyst	0(0/34)	8.3(5/60)	0.084

Table 5 Comparison of patients with severe hyperlipidemic pancreatitis receiving plasma exchange and not receiving plasma exchange

Ranson >3	Group A: PE (+) (%, n = 10)	Group B: PE (-) (%, n = 19)	P value
Mortality	30(3)	15.8(3)	0.369
Systemic complications	70(7)	42.1(8)	0.153
Local complications	10(1)	21.1(4)	0.454

PE (+): With plasma exchange; PE (-): Without plasma exchange.